Polio in Africa {#cesec10}
===============

Laboratory tests have confirmed that the Côte ďIvoire has become the eighth polio-free African country to be re-infected from Nigeria. Its last polio case was reported in July 2000. The Northern states of Kano have not resumed immunisation as hoped by the donor organisations as the safety issues surrounding the vaccine have still not been resolved. Rumours that Nigeria will procure their vaccines from elsewhere are unfounded. David Heymann (WHO) told *TLID*, "Nigeria have a contract with Unicef to get their vaccines, which come from various companies around the world. There is just not enough vaccine produced from the one Islamic country producer, Indonesia, for all the needs of Nigeria". Further immunisations are to take place across Africa on March 22, and Islamic countries elsewhere have already led vigorous vaccination programmes to set an example. Heymann says, "its clear the solutions have to come from Nigeria".

Dengue in Indonesia {#cesec20}
===================

Indonesia is struggling to control one of the worst dengue outbreaks seen in years. As of March 7, 2004, the death toll has reached 389, with the number of cases rising to 226 013. 26 of Indonesia\'s 32 provinces are affected, and the predominant serotype is dengue 3, but all four serotypes are involved. At first it was thought the outbreak was a result of a more virulent strain of the virus. But Georg Petersen (WHO\'s representative in Indonesia), said that was unlikely. He said the outbreak this year was likely to be part of a 5-year cycle common in tropical countries. "The main reason for the huge impact is the immunity in the population is lower."

The country\'s health authorities are conducting intensive vector control activities, while the government is providing free hospital treatment to those dengue patients who cannot afford it.

Encephalitis in Bangladesh {#cesec30}
==========================

An outbreak of encephalitis caused by a Nipah virus has been confirmed in Bangladesh. As of February 26, WHO received reports of 22 cases, including 17 deaths. Most of the cases were in children and the symptoms included fever, headache, vomiting, and spells of unconsciousness. Nima Asgari part of the WHO investigation team told *TLID* that it was not difficult to isolate the virus, but that by the time they arrived, a lot of the patients had died. "The virus is from one particular species of the fruit bat, the flying fox, but unlike in the Malaysian outbreak where the pig was the intermediate host, here we are still trying to identify an animal vector, and so the question is what is the mechanism by which patients became infected from the fruit bat", he said.

Yellow fever in Liberia {#cesec40}
=======================

As of March 9, 2004, 39 cases of yellow fever including eight deaths have been reported. 66% of the target population (47 763) have been immunised. Additional emergency mass immunisation campaigns are planned to start on March 20 2004. Lizitu Simao (WHO in Liberia) said this was a more severe outbreak than previous years. "The 14-year civil war has destroyed the health care infrastructure, routine immunisation stopped, and many populations have never been vaccinated", he added.

Avian influenza {#cesec50}
===============

The most widespread bird flu epidemic in Asia has more than totalled the world\'s five previous largest outbreaks combined. Both the UN and WHO have warned that it could take years to bring the present outbreaks under control. Over the past months, more than 100 million birds have either died of the disease caused by the virulent H5N1 strain, or been culled in Asia, while there have been 33 confirmed cases of the disease\'s transmission to humans, 22 of them fatal, seven in Thailand and 15 in Vietnam.

**Flu and SARS vaccine update**WHO announces the influenza vaccine composition for the 2004/2005 Northern hemisphere season. The vaccine will contain an A/New Caledonia/20/99 (H1N1)-like virus, an A/Fujian/411/2002 (H3N2)-like virus. and a B/Shanghai/361/2002-like virus. Klaus Stohr (WHO) told *TLID*, "we did not include H5N1 since, though the strain is easy to transmit from birds to human beings, it is not changing its characteristics, and is not becoming more transmissible in human beings".The avian flu vaccine is progressing to schedule. The trials for pathogenicity and safety of the recombinant virus will be finished end of March/early April. If everything is successful, the virus will be given to companies who will produce small batches of the so-called clinical vaccine, which will then be used in human phase I and II trials.China is beginning the first phase of clinical human trials of an experimental severe acute respiratory syndrome (SARS) vaccine. 30 volunteers between the ages of 18 and 40 will participate in the first clinical trial spanning over 3 months. So far, the experimental vaccine proved safe when tested on animals.

In the USA, farms in Texas, Delaware, and Maryland have also had outbreaks but of the H5N2 strain. Reports of an avian outbreak in a farm in British Columbia, Canada where the disease has never been reported is also of concern. Here, tests have found both mild and severe strains of the H7 in samples. Experts have stressed that both strains do not pose an immediate threat to human beings.

Klaus Stohr (WHO) states that the Asian influenza outbreak situation has improved dramatically but warned that the concentration of poultry in backyard farms, the economic impact of the industry, and lack of experience in dealing with these epidemics could hamper disease control measures.
